keyword
https://read.qxmd.com/read/38613687/criminal-behavior-in-alcohol-related-dementia-and-wernicke-korsakoff-syndrome-a-nationwide-register-study
#21
JOURNAL ARTICLE
Anniina Palm, Tiina Talaslahti, Risto Vataja, Milena Ginters, Hannu Kautiainen, Henrik Elonheimo, Jaana Suvisaari, Nina Lindberg, Hannu Koponen
BACKGROUND: Chronic heavy alcohol use may lead to permanent brain damage, cognitive impairment, and dementia. While the link between alcohol use and crime is strong, virtually no research exists on the criminal behavior of patients with the alcohol-related neurocognitive disorders of Wernicke-Korsakoff syndrome (WKS) and alcohol-related dementia (ARD). METHODS: The study population included all persons diagnosed with WKS (n = 1149) or ARD (n = 2432) in Finland in 1998-2015...
April 13, 2024: European Archives of Psychiatry and Clinical Neuroscience
https://read.qxmd.com/read/38610121/the-effect-of-repeated-concussions-on-clinical-and-neurocognitive-symptom-severity-in-different-contact-sports
#22
MULTICENTER STUDY
Jennifer Glaser, Sarah Jaeckle, Thomas Beblo, Gerhard Mueller, Andreas M Eidenmueller, Philipp Schulz, Ingo Schmehl, Witold Rogge, Karsten Hollander, Max Toepper, Andreas S Gonschorek
INTRODUCTION: The potential consequences of repeated concussions in sport are well documented. However, it remains unclear whether the cumulative impact of sports-related concussions differs between different contact sports. Therefore, the aim of the current study was to investigate the cumulative effects of sports-related concussions on clinical and neurocognitive health in different contact sports. MATERIALS AND METHODS: In a prospective multicenter study, we examined 507 (74 females) active professional athletes between 18 and 40 years of age from five different contact sports (soccer, handball, American football, basketball, and ice hockey)...
April 2024: Scandinavian Journal of Medicine & Science in Sports
https://read.qxmd.com/read/38610055/risk-of-conversion-to-mild-cognitive-impairment-or-dementia-among-subjects-with-amyloid-and-tau-pathology-a-systematic-review-and-meta-analysis
#23
REVIEW
Zsolt Huszár, Marie Anne Engh, Márk Pavlekovics, Tomoya Sato, Yalea Steenkamp, Bernard Hanseeuw, Tamás Terebessy, Zsolt Molnár, Péter Hegyi, Gábor Csukly
BACKGROUND: Measurement of beta-amyloid (Aβ) and phosphorylated tau (p-tau) levels offers the potential for early detection of neurocognitive impairment. Still, the probability of developing a clinical syndrome in the presence of these protein changes (A+ and T+) remains unclear. By performing a systematic review and meta-analysis, we investigated the risk of mild cognitive impairment (MCI) or dementia in the non-demented population with A+ and A- alone and in combination with T+ and T- as confirmed by PET or cerebrospinal fluid examination...
April 12, 2024: Alzheimer's Research & Therapy
https://read.qxmd.com/read/38610004/clinical-investigator-perspectives-on-patient-outcomes-in-children-with-neuronopathic-mucopolysaccharidosis-ii-during-intrathecal-idursulfase-it-treatment
#24
JOURNAL ARTICLE
Karen S Yee, David Alexanderian, Susan Martin, Bimpe Olayinka-Amao, David A H Whiteman
BACKGROUND: Mucopolysaccharidosis II (MPS II) is a rare lysosomal storage disease characterized by iduronate-2-sulfatase gene (IDS) deficiency and downstream glycosaminoglycan accumulation. Two-thirds of patients present with neuronopathic disease and evaluating cognitive function in these patients is challenging owing to limitations of currently available tests. During the clinical development of intrathecal idursulfase (idursulfase-IT), regulatory authorities requested qualitative data to further understand the neurocognitive changes observed by the investigators through the clinical trials...
April 12, 2024: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/38608417/the-matrics-consensus-cognitive-battery-for-the-assessment-of-cognitive-impairment-in-schizotypal-personality-disorder
#25
JOURNAL ARTICLE
Katelyn N Challman, Daniel R Rosell, Deanna Barch, Harold W Koenigsberg, Philip D Harvey, Erin A Hazlett, M Mercedes Perez-Rodriguez, Antonia S New, Margaret McNamara McClure
Cognitive deficits are a core impairment across the range of schizophrenia (SZ) spectrum disorders, including schizotypal personality disorder (SPD). The MATRICS Consensus Cognitive Battery (MCCB) was developed to be a robust, specific, and valid cognitive assessment battery to assess cognition in clinical trials for treating cognitive impairments in SZ. Despite the similarity of cognitive impairments shown in SPD and SZ and the clear relevance of uniform assessment across a diagnostic spectrum, the MCCB has yet to be validated in SPD...
April 11, 2024: Schizophrenia Research
https://read.qxmd.com/read/38605461/cerebellum-purkinje-cell-vulnerability-in-aged-rats-with-memory-impairment
#26
JOURNAL ARTICLE
C'iana P Cooper, Liam H Cheng, Jafar A Bhatti, Edward L Rivera, Derek Huell, Cristina Banuelos, Evelyn J Perez, Jeffrey M Long, Peter R Rapp
The cerebellum is involved in higher order cognitive function and is susceptible to age-related atrophy. However, limited evidence has directly examined the cerebellum's role in cognitive aging. To interrogate potential substrates of the relationship between cerebellar structure and memory in aging, here we target the Purkinje cells (PCs). The sole output neurons of the cerebellum, PC loss and/or degeneration underlie a variety of behavioral abnormalities. Using a rat model of normal cognitive aging, we immunostained sections through the cerebellum for the PC-specific protein, calbindin-D28k...
April 2024: Journal of Comparative Neurology
https://read.qxmd.com/read/38604094/orthostatic-hypotension-and-cognitive-impairment-systematic-review-and-meta-analysis-of-longitudinal-studies
#27
REVIEW
Guillaume T Duval, Eve Raud, Hugo Gohier, Moustapha Dramé, Maturin Tabue-Teguo, Cédric Annweiler
The association between cognitive disorders and orthostatic hypotension (OH) has been empirically explored, but the results have been divergent, casting doubt on the presence and direction of the association. The objective of this meta-analysis was to systematically review and quantitatively synthesize the association of OH and cognitive function, specifically mean score on the Mini-Mental State Examination (MMSE), cognitive impairment and incident dementia. A Medline search was conducted in May 2022 with no date limit, using the MeSH terms "orthostatic hypotension" OR "orthostatic intolerance" OR "hypotension" combined with the Mesh terms "cognitive dysfunction" OR "Alzheimer disease" OR "dementia" OR "cognition disorder" OR "neurocognitive disorder" OR "cognition" OR "neuropsychological test"...
November 2, 2023: Maturitas
https://read.qxmd.com/read/38603641/impact-of-propofol-exposure-on-neurocognitive-outcomes-in-children-with-high-risk-b-all-a-children-s-oncology-group-study
#28
JOURNAL ARTICLE
Sarah Alexander, John A Kairalla, Sumit Gupta, Emily Hibbitts, Hannah Weisman, Doralina Anghelescu, Naomi J Winick, Kevin R Krull, Wanda L Salzer, Michael J Burke, Lia Gore, Meenakshi Devidas, Leanne Embry, Elizabeth A Raetz, Stephen P Hunger, Mignon L Loh, Kristina K Hardy
PURPOSE: Many children treated for ALL develop long-term neurocognitive impairments. Increased risk of these impairments is associated with treatment and demographic factors. Exposure to anesthesia is an additional possible risk factor. This study evaluated the impact of cumulative exposure to anesthesia on neurocognitive outcomes among a multicenter cohort of children with ALL. METHODS: This study was embedded in AALL1131, a Children's Oncology Group phase III trial for patients with high-risk B-ALL...
April 11, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38602558/the-impact-of-cannabis-use-on-cognition-in-people-with-hiv-evidence-of-function-dependent-effects-and-mechanisms-from-clinical-and-preclinical-studies
#29
REVIEW
Samantha M Ayoub, Breanna M Holloway, Alannah H Miranda, Benjamin Z Roberts, Jared W Young, Arpi Minassian, Ronald J Ellis
PURPOSE OF REVIEW: Cannabis may have beneficial anti-inflammatory effects in people with HIV (PWH); however, given this population's high burden of persisting neurocognitive impairment (NCI), clinicians are concerned they may be particularly vulnerable to the deleterious effects of cannabis on cognition. Here, we present a systematic scoping review of clinical and preclinical studies evaluating the effects of cannabinoid exposure on cognition in HIV. RECENT FINDINGS: Results revealed little evidence to support a harmful impact of cannabis use on cognition in HIV, with few eligible preclinical data existing...
April 11, 2024: Current HIV/AIDS Reports
https://read.qxmd.com/read/38601836/a-unique-delusion-with-depression-in-early-stage-of-neurocognitive-disorder-due-to-vascular-disease-considerations-for-clinicians
#30
REVIEW
Mounica Thootkur, Binx Yezhe Lin, Akhil S Pola, Alexander Zhang, Zhengshan Liu, Michael Greenage, Justin White, Mamta Sapra
As global aging becomes more prominent, neurocognitive disorders (NCD) incidence has increased. Patients with NCD usually have an impairment in one or more cognitive domains, such as attention, planning, inhibition, learning, memory, language, visual perception, and spatial or social skills. Studies indicate that 50-80% of these adults will develop neuropsychiatric symptoms (NPS), such as apathy, depression, anxiety, disinhibition, delusions, hallucinations, and aberrant motor behavior. The progression of NCD and subsequent NPS requires tremendous care from trained medical professionals and family members...
April 4, 2024: Psychopharmacology Bulletin
https://read.qxmd.com/read/38600307/modeling-hiv-1-infection-and-neurohiv-in-hipscs-derived-cerebral-organoid-cultures
#31
JOURNAL ARTICLE
Martina Donadoni, Senem Cakir, Anna Bellizzi, Michael Swingler, Ilker K Sariyer
The human immunodeficiency virus (HIV) epidemic is an ongoing global health problem affecting 38 million people worldwide with nearly 1.6 million new infections every year. Despite the advent of combined antiretroviral therapy (cART), a large percentage of people with HIV (PWH) still develop neurological deficits, grouped into the term of HIV-associated neurocognitive disorders (HAND). Investigating the neuropathology of HIV is important for understanding mechanisms associated with cognitive impairment seen in PWH...
April 10, 2024: Journal of Neurovirology
https://read.qxmd.com/read/38598467/language-outcomes-of-preschool-children-who-are-hiv-exposed-uninfected-an-analysis-of-a-south-african-cohort
#32
JOURNAL ARTICLE
Freddy Green, Christopher du Plooy, Andrea M Rehman, Raymond T Nhapi, Marilyn T Lake, Whitney Barnett, Nadia Hoffman, Heather J Zar, Kirsten A Donald, Dan J Stein, Catherine J Wedderburn
INTRODUCTION: There are approximately 16 million children who are HIV-exposed and uninfected (CHEU) worldwide. Studies suggest that CHEU are at risk for developmental impairment in infancy, particularly in language domains. However, there is limited research examining neurocognitive function in CHEU older than 2 years, including important pre-school years. This study aimed to investigate associations between HIV exposure without infection and neurocognitive outcomes and to determine risk factors for neurodevelopment in CHEU at age 3-4 years...
2024: PloS One
https://read.qxmd.com/read/38593743/weighing-the-role-of-social-cognition-and-executive-functioning-in-pragmatics-in-the-schizophrenia-spectrum-a-systematic-review-and-meta-analysis
#33
JOURNAL ARTICLE
Federico Frau, Chiara Cerami, Alessandra Dodich, Marta Bosia, Valentina Bambini
Pragmatic impairment is diffused in schizophrenia spectrum disorders, but the literature still debates its neurocognitive underpinnings. This systematic review and meta-analysis aimed to investigate the neurocognitive correlates of pragmatic disorders in schizophrenia and determine the weight of social cognition and executive functioning on such disorders. Of the 2,668 records retrieved from the literature, 16 papers were included in the systematic review, mostly focused on non-literal meanings and discourse production in schizophrenia...
April 8, 2024: Brain and Language
https://read.qxmd.com/read/38592295/neurocognitive-changes-in-patients-with-post-covid-depression
#34
JOURNAL ARTICLE
Marina Khodanovich, Anna Naumova, Daria Kamaeva, Victoria Obukhovskaya, Svetlana Vasilieva, Evgeny Schastnyy, Nadezhda Kataeva, Anastasia Levina, Marina Kudabaeva, Valentina Pashkevich, Marina Moshkina, Yana Tumentceva, Mikhail Svetlik
Background : Depression and cognitive impairment are recognized complications of COVID-19. This study aimed to assess cognitive performance in clinically diagnosed post-COVID depression (PCD, n = 25) patients using neuropsychological testing. Methods : The study involved 71 post-COVID patients with matched control groups: recovered COVID-19 individuals without complications (n = 18) and individuals without prior COVID-19 history (n = 19). A post-COVID depression group (PCD, n = 25) was identified based on psychiatric diagnosis, and a comparison group (noPCD, n = 46) included participants with neurological COVID-19 complications, excluding clinical depression...
March 1, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38592199/heterogeneity-in-measures-of-illness-among-patients-with-myalgic-encephalomyelitis-chronic-fatigue-syndrome-is-not-explained-by-clinical-practice-a-study-in-seven-u-s-specialty-clinics
#35
JOURNAL ARTICLE
Elizabeth R Unger, Jin-Mann S Lin, Yang Chen, Monica E Cornelius, Britany Helton, Anindita N Issa, Jeanne Bertolli, Nancy G Klimas, Elizabeth G Balbin, Lucinda Bateman, Charles W Lapp, Wendy Springs, Richard N Podell, Trisha Fitzpatrick, Daniel L Peterson, C Gunnar Gottschalk, Benjamin H Natelson, Michelle Blate, Andreas M Kogelnik, Catrina C Phan, On Behalf Of The McAm Study Group
Background: One of the goals of the Multi-site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM) study was to evaluate whether clinicians experienced in diagnosing and caring for patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) recognized the same clinical entity. Methods: We enrolled participants from seven specialty clinics in the United States. We used baseline data (n = 465) on standardized questions measuring general clinical characteristics, functional impairment, post-exertional malaise, fatigue, sleep, neurocognitive/autonomic symptoms, pain, and other symptoms to evaluate whether patient characteristics differed by clinic...
February 28, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38588518/-clustering-of-cognitive-domains-among-older-adults-with-hiv
#36
JOURNAL ARTICLE
Virgilio Hernández-Ruiz, Carlos A Ruiz-Manríquez, Omar Y Bello-Chavolla, Hélène Amieva, José A Avila-Funes
BACKGROUND: Age and HIV are synergistic risk factors for conditions such as HIV-associated neurocognitive disorders (HAND). Yet, it is unclear whether OAWH display different cognitive profiles for HAND. OBJECTIVE: To describe the cognitive patterns of OAWH treated with combined antiretroviral therapy (cART). METHODS: Cross-sectional study that included 330 participants with HIV, aged 50 years or older, cared for at a tertiary care hospital in Mexico City...
April 8, 2024: Gaceta Médica de México
https://read.qxmd.com/read/38588024/unravelling-the-triad-of-neuroinvasion-neurodissemination-and-neuroinflammation-of-human-immunodeficiency-virus-type-1-in-the-central-nervous-system
#37
REVIEW
Marta Calado, Rita Ferreira, David Pires, Quirina Santos-Costa, Elsa Anes, Dora Brites, José Miguel Azevedo-Pereira
Since the identification of human immunodeficiency virus type 1 (HIV-1) in 1983, many improvements have been made to control viral replication in the peripheral blood and to treat opportunistic infections. This has increased life expectancy but also the incidence of age-related central nervous system (CNS) disorders and HIV-associated neurodegeneration/neurocognitive impairment and depression collectively referred to as HIV-associated neurocognitive disorders (HAND). HAND encompasses a spectrum of different clinical presentations ranging from milder forms such as asymptomatic neurocognitive impairment or mild neurocognitive disorder to a severe HIV-associated dementia (HAD)...
May 2024: Reviews in Medical Virology
https://read.qxmd.com/read/38586191/associations-of-sleep-disorders-with-all-cause-mci-dementia-and-different-types-of-dementia-clinical-evidence-potential-pathomechanisms-and-treatment-options-a-narrative-review
#38
REVIEW
Geert Mayer, Helmut Frohnhofen, Martha Jokisch, Dirk M Hermann, Janine Gronewold
Due to worldwide demographic change, the number of older persons in the population is increasing. Aging is accompanied by changes of sleep structure, deposition of beta-amyloid (Aß) and tau proteins and vascular changes and can turn into mild cognitive impairment (MCI) as well as dementia. Sleep disorders are discussed both as a risk factor for and as a consequence of MCI/dementia. Cross-sectional and longitudinal population-based as well as case-control studies revealed sleep disorders, especially sleep-disorderded breathing (SDB) and excessive or insufficient sleep durations, as risk factors for all-cause MCI/dementia...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38579478/peripheral-inflammation-is-associated-with-impaired-sadness-recognition-in-euthymic-bipolar-patients
#39
JOURNAL ARTICLE
Chih-Yu Chang, Hui Hua Chang, Cheng Ying Wu, Ying Tsung Tsai, Tsung-Hua Lu, Wei Hung Chang, Chia-Fen Hsu, Po See Chen, Huai-Hsuan Tseng
BACKGROUND: Inflammation impairs cognitive function in healthy individuals and people with psychiatric disorders, such as bipolar disorder (BD). This effect may also impact emotion recognition, a fundamental element of social cognition. Our study aimed to investigate the relationships between pro-inflammatory cytokines and emotion recognition in euthymic BD patients and healthy controls (HCs). METHODS: We recruited forty-four euthymic BD patients and forty healthy controls (HCs) and measured their inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and TNF-α...
March 28, 2024: Journal of Psychiatric Research
https://read.qxmd.com/read/38576072/neuropsychological-functioning-and-its-correlates-at-1-year-follow-up-of-severe-covid-19
#40
JOURNAL ARTICLE
Ana Costas-Carrera, Marta Mónica Sánchez-Rodríguez, Antonio Ojeda, Manuel Arturo Rodríguez-Rey, Inés Martín-Villalba, Mireia Primé-Tous, Francisco Valdesoiro-Pulido, Xavier Segú, Roger Borras, Derek Clougher, Josep Maria Peri, Eduard Vieta
BACKGROUND: Short-term cognitive impairment is associated with SARS-CoV-2 infection but the long-term impact is yet to be examined in detail. We aim to study the evolution of these symptoms in severe COVID-19 patients admitted to the intensive care unit (ICU) between April and December 2020 1 year after hospital discharge and to analyze its clinical correlates. METHOD: A total of 58 patients agreed to participate in the 6 months follow-up and 30 at 1 year after hospital discharge...
April 4, 2024: Psychogeriatrics: the Official Journal of the Japanese Psychogeriatric Society
keyword
keyword
164006
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.